RxDoctor Payments Data

Jose Jimenez-Almonte

Orthopaedic Surgery of the Spine · Debary, FLNPI 1619359452

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (49.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 53.9% of the total. Reporting peaked in 2021 at $78,952 and has fallen 81.5% since, to $14,642 in 2025.

$152,462in general payments, 2019–2025

Across 197 payments — averaging $773.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$82K
  • Highridge Medical LLC$40K
  • Alphatec Spine, Inc$6K
  • Theragen, Inc.$5K
  • Zimvie Inc.$4K
  • Eminent Spine, LLC$4K
  • plus $11K from 23 others

What the payments were for

  • Consulting fees$53,53835%
  • Grants$75,00049%
  • Travel & lodging$16,87111%
  • Food & beverage$5,8544%
  • Education$1,2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$152,462 in reported general payments places this provider in the 75th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$102,441
Medicare patients
213
Services billed
805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone149$1,090
Methocarbamol153$909
Gabapentin97$537
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$325
Ondansetron OdtOndansetron52$307
Meloxicam64$243
Cyclobenzaprine Hcl18$164
Mupirocin23$148
Pregabalin12$120
Tramadol Hcl21$57

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Debary

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →